# Predictors of Sorafenib Response in HCC

> **NCT05967429** · — · UNKNOWN · sponsor: **Sohag University** · enrollment: 80 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** The neutrophil-to- lymphocyte ratio
- **DIAGNOSTIC_TEST:** Prognostic nutrition index

## Key facts

- **NCT ID:** NCT05967429
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08
- **Primary completion:** 2024-04
- **Final completion:** 2024-06
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05967429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05967429, "Predictors of Sorafenib Response in HCC". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05967429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*